# PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

> **NCT00362973** · — · COMPLETED · sponsor: **University of Washington** · enrollment: 42 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** needle biopsy
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** radionuclide imaging
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT00362973
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2009-11
- **Final completion:** —
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362973, "PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00362973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*